Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06324955 · ClinicalTrials.gov registry record · NA
Language During Inhalational Induction
A NA study of Emergence Delirium and Anesthesia; Adverse Effect, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 1
- Study location
NCT06324955: Recruiting NA study of Emergence Delirium and Anesthesia; Adverse Effect, sponsored by Boston Children's Hospital.
NCT06324955 is a NA study of Emergence Delirium and Anesthesia; Adverse Effect that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 128 participants, above the 107-participant average among 3 other Emergence Delirium trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06324955, a NA study of Emergence Delirium and Anesthesia; Adverse Effect, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to compare the impact of common (standard of care) language vs positive language used by clinicians during inhalational induction of anesthesia on anxiety and negative behaviors in children. This is a prospective randomized parallel group trial. Patients will be randomized 1:1 to the common/standard language group or the positive language group.
Primary Outcome
Compliance of children during mask induction as measured by the Induction Compliance Checklist (ICC) from the time patient enters the operating room until loss of lid reflex
Conditions Studied
Interventions
- BEHAVIORAL Standard/common language during induction
- BEHAVIORAL Positive language during induction
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2024-04-08 |
| Est. Completion | 2027-04 |
| Phase | NA |
What NCT06324955 shows while recruiting
NCT06324955 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, above the 107-participant average among 3 other Emergence Delirium trials with a reported enrollment target (20% higher).
The record links to 2 conditions, with Emergence Delirium appearing as the primary indexed condition, and to 2 interventions - of which Standard/common language during induction is the first listed.
NCT06324955 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06324955 about?
NCT06324955 is a clinical study titled "Language During Inhalational Induction". The aim of this study is to compare the impact of common (standard of care) language vs positive language used by clinicians during inhalational induction of anesthesia on anxiety and negative behaviors in children. This is a prospective randomized parallel group trial. Patients will be randomized 1...
What is the current status of trial NCT06324955?
This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2024-04-08. Estimated completion is 2027-04.
What conditions does trial NCT06324955 study?
This clinical trial studies the following conditions: Emergence Delirium, Anesthesia; Adverse Effect.
What interventions are being tested in trial NCT06324955?
The interventions under investigation include: Standard/common language during induction (BEHAVIORAL), Positive language during induction (BEHAVIORAL).
Who is sponsoring clinical trial NCT06324955?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06324955 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emergence Delirium
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI